Adult Vaccine Alliance / Alliance Vaccins pour Adultes

📣 Upcoming Webinar 📣 Closing the Gap in Pneumococcal Vaccination for Older Adults: What You Need to Know Although the PHAC has set a target of 80% pneumococcal vaccination coverage, only 54.7% of Canadians aged 65+ were vaccinated as of 2023. Dr. Sinha and Dr. Jia Hu, co-founder of 19 To Zero, will discuss the urgent need to improve pneumococcal vaccination rates among older adults and share policy and practice recommendations to address this gap. Join us for this important conversation! 📅 : Wednesday, November 20 ⏰ : 12:00 – 1:00 pm EST 💻 : Zoom 🔗 :   https://lnkd.in/gXNHEVj4

Pleased to see coverage last week by Chris Hannay on AVA's report on the unmet value of vaccines. ⬇️ Read the article: https://lnkd.in/eMZ-cQfN

Every member brings a unique vision to the Adult Vaccine Alliance. Here is what AVA member, Catherine Paquette, National Senior Manager, Vaccines Access & Provincial Affairs at Pfizer Canada, had to say.

The Adult Vaccine Alliance unites experts dedicated to advancing adult immunization through improved funding, awareness and access. Hear from Dr. Vivien Brown as she shares what inspired her to join the Alliance.

For every $1 invested in adult vaccines, Canada sees a return of more than 3X in health and economic benefits (341%). A new study by the Adult Vaccine Alliance (AVA) shows the powerful impact of vaccines like influenza, COVID-19, and shingles. AVA is advocating for increased funding and access to boost vaccine uptake across the country. Read the full study: https://lnkd.in/d3JFRWBp

AVA est fière d'annoncer la publication d'une nouvelle étude exhaustive démontrant les avantages significatifs pour la santé et l'économie d'une hausse de la couverture vaccinale des adultes au Canada. En plus de protéger contre les maladies graves et les épidémies, l'étude révèle que la prise de vaccins pour adultes, tels que ceux contre la grippe, la COVID-19, le zona et la pneumonie, peuvent générer 2,5 milliards de dollars supplémentaires pour les soins de santé et l'économie canadienne, de plus, une légère augmentation de 10 % de la prise de vaccination pourrait entraîner des bénéfices supplémentaires annuels de 685 millions de dollars. L'étude exhaustive est affichée en ligne à : https://lnkd.in/d3JFRWBp

The Adult Vaccine Alliance (AVA) is proud to announce a comprehensive new study, commissioned from IQVIA, highlighting the significant health and economic benefits of increasing adult vaccination rates in Canada. Beyond protecting against serious diseases and outbreaks, the study reveals that adult vaccines, such as those for influenza, COVID-19, shingles, and pneumonia, bring $2.5 billion in health care and economic benefit to Canada and that a modest 10% increase in vaccination rates could bring additional benefits of $685 million each year. Read the full study: https://lnkd.in/d3JFRWBp

The Adult Vaccine Alliance brings together a group of immunization experts to advocate for better funding for, increased awareness of, and better access to NACI-recommended adult vaccines in Canada. Curious about what motivates our members? Hear from AVA member Catherine Paquette of Pfizer, as she explains what drew her to join the Adult Vaccine Alliance.

As fall arrives, so does the increase in respiratory illnesses. Tune into the latest episode of The Dose podcast to hear about the latest vaccines and treatments for influenza, COVID-19, and RSV, plus tips on staying safe this season. 🎙️ https://lnkd.in/eebxCTZR

It’s National Immunization Awareness Month! Adult vaccines play a crucial role in keeping our communities healthy. AVA is advocating for better access to adult vaccines in Canada – improving health and saving lives. Learn more at AdultVaccineAlliance.ca #NIAM2024 #ImmunizationAwareness #VaccinesWork #AdultVaccineAlliance